Physician profile
Diane Bray
NPI 1225094642
$1,213.15
in general payments reported to CMS, 2019-2025
22 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $107 · 2022: $109 · 2023: $492 · 2024: $265 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $997.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $146.82 | 2024-2025 | |
| Stryker Corporation | $136.07 | 2023-2024 | Hoffmann, Allograft, Anchorage |
| Grt US Holding, INC. | $108.46 | 2021-2022 | |
| Tactile Systems Technology INC | $100.43 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Medtronic, INC. | $98.23 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
| Averitas Pharma INC. | $85.90 | 2023-2024 | Qutenza |
| Organogenesis INC. | $73.93 | 2023-2025 | Puraply, Via Matrix |
| Abbvie INC. | $58.83 | 2022-2023 | Teflaro, Dalvance |
| Kerecis Limited | $54.20 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Paratek Pharmaceuticals, INC. | $53.67 | 2024-2025 | Nuzyra |
| Smith+Nephew, INC. | $52.34 | 2023-2025 | Grafix Pl, Stravix |
| Convatec INC. | $34.25 | 2023-2024 | |
| Kci USA, INC. | $31.93 | 2023 | Activ.A.C., Promogran Prisma, Kerramax Care |
| Nevro Corp. | $31.51 | 2022-2024 | Senza |
| Reapplix INC. | $29.33 | 2023 | 3c Patch Kit - Box |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $22.29 | 2025 | Purified Cortrophin Gel |
| Djo, LLC | $19.79 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $16.73 | 2025 | |
| Solventum Corporation | $16.43 | 2025 | Activ.A.C. |
| Reddress USA, INC. | $15.16 | 2021 | |
| Zimvie INC. | $13.78 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $13.07 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Bray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.